There is a clear slowdown in India and so the pharma major expects only 18-20 percent growth here in FY2014, Glenn Saldanha, CEO & MD told CNBC-TV18. Also Read: Don't see large commercial sales this year, says Brigade Enterprises In the US market, ... Moneycontrol.com, 1 month ago
Glenmark braves challenges to focus on US mkt - Moneycontrol.com, 1 month ago
3 images for "glenn saldanha"
North America is the largest pharmaceutical market for the drug firms of the world. And the importance of this market has been highlighted by the quarterly numbers posted by Indian pharmaceutical giants. For Lupin , revenues from the US market grew ...Moneycontrol.com, 1 month ago
Glenmark Pharma sees its overall sales growing at a slower 20% this fiscal from the 38% pace logged in the last fiscal on account slowdown in India and delay in US drug approvals. Glenmark Pharma sees its overall sales growing at a slower 20% this ...DNA India, 1 month ago
Glenmark Pharmaceuticals rose 1.35% to Rs 527.70 at 9:22 IST on BSE after consolidated net profit rose 10.9% to Rs 166.79 crore on 25.3% growth in revenue to Rs 1335.48 crore in Q4 March 2013 over Q4 March 2012. The company announced the result ...India Infoline, 1 month ago Glenmark Q4 Net up 11 pc at Rs 167 crore Economic Times, 1 month ago Glenmark Pharma net profit up by 11% in Q4, dividend at 200% PharmaBiz, 1 month ago Glenmark Q4 net up 11 per cent at Rs 167 crore NDTV Profit, 1 month ago
Drug-maker Glenmark said that its specialty drugs and generics businesses performed well in the year ended March 2013. "The US, India and Russia businesses continued to maintain its high growth trajectory," said Glenn Saldanha, Chairman and Managing ...Hindu Business Line, 1 month ago
The Specialty formulation business excluding out-licensing revenue was at Rs. 7412.94 Mn (USD 136.48 Mn) as against Rs. 5943.75Mn (USD 116.98 Mn) for the corresponding previous quarter, recording a growth of 24.72 % in Rs. term over the previous ...India Infoline, 1 month ago Glenmark's Consolidated Revenue Increases by 33.96% to Rs. 13812.59 Million for Q3 FY 12-13 AndhraNews.net, 2 months ago
on your WebpageAdd Widget >Get your members hooked!